Alert detail
LCD L39877: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound — First Coast
What changed
Final LCD restricts amniotic/placental injections for MSK indications in FL/PR/V
Who’s affected: Orthopedics billing teams · Effective: December 1, 2024
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 10 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.